市場調査レポート
商品コード
1566991

二相性ヒアルロン酸フィラー市場:パイプラインレポート(開発段階、セグメント、地域・国、規制経路、主要企業)、2024最新版

Biphasic Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


出版日
発行
GlobalData
ページ情報
英文 42 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
二相性ヒアルロン酸フィラー市場:パイプラインレポート(開発段階、セグメント、地域・国、規制経路、主要企業)、2024最新版
出版日: 2024年09月17日
発行: GlobalData
ページ情報: 英文 42 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

二相性ヒアルロン酸フィラーは、異なる化学組成を持つ2つ以上の物質から構成されます。二相性ヒアルロン酸フィラーは、治療される解剖学的部位に適した粒子サイズを得るために、より容易にカスタマイズされます。

当レポートでは、二相性ヒアルロン酸フィラー市場について調査し、製品概要と開発中のパイプライン製品動向、様々な開発段階にある製品の比較分析や進行中の臨床試験に関する情報、参入企業の最近の動向などを提供しています。

目次

第1章 目次

第2章 イントロダクション

  • 二相性ヒアルロン酸フィラーの概要

第3章 開発中の製品

  • 二相性ヒアルロン酸フィラー - 開発段階別パイプライン製品
  • 二相性ヒアルロン酸フィラー - 地域別パイプライン製品
  • 二相性ヒアルロン酸フィラー - 規制経路別パイプライン製品
  • 二相性ヒアルロン酸フィラー - 推定承認日別パイプライン製品
  • 二相性ヒアルロン酸フィラー - 進行中の臨床試験

第4章 二相性ヒアルロン酸フィラー- 各社が開発中のパイプライン製品

  • 二相性ヒアルロン酸フィラー企業- 開発段階別のパイプライン製品
  • 二相性ヒアルロン酸フィラー- 開発段階別のパイプライン製品

第5章 二相性ヒアルロン酸フィラーの企業と製品概要

  • Croma-Pharma GmbH
  • Hangzhou Singclean Medical Products Co Ltd
  • LG Chem Ltd
  • LifeSprout Inc
  • Mesoestetic Pharma Group SL
  • Silk Medical Aesthetics Inc
  • Sinclair Pharma Ltd
  • SwiftPharma BV

第6章 付録

図表

List of Tables

  • Biphasic Hyaluronic Acid Fillers - Pipeline Products by Stage of Development
  • Biphasic Hyaluronic Acid Fillers - Pipeline Products by Territory
  • Biphasic Hyaluronic Acid Fillers - Pipeline Products by Regulatory Path
  • Biphasic Hyaluronic Acid Fillers - Pipeline Products by Estimated Approval Date
  • Biphasic Hyaluronic Acid Fillers - Ongoing Clinical Trials
  • Biphasic Hyaluronic Acid Fillers Companies - Pipeline Products by Stage of Development
  • Biphasic Hyaluronic Acid Fillers - Pipeline Products by Stage of Development
  • Glossary

List of Figures

  • Biphasic Hyaluronic Acid Fillers - Pipeline Products by Stage of Development
  • Biphasic Hyaluronic Acid Fillers - Pipeline Products by Territory
  • Biphasic Hyaluronic Acid Fillers - Pipeline Products by Regulatory Path
  • Biphasic Hyaluronic Acid Fillers - Pipeline Products by Estimated Approval Date
  • Biphasic Hyaluronic Acid Fillers - Ongoing Clinical Trials
目次
Product Code: GDME1815EPD

GlobalData's Medical Devices sector report, "Biphasic Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Biphasic Hyaluronic Acid Fillers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Biphasic Hyaluronic Acid Fillers consist of two or more substances with different chemical compositions. Biphasic HA fillers are more easily customized to obtain the appropriate particle size to suit the anatomical area being treated.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Biphasic Hyaluronic Acid Fillers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Biphasic Hyaluronic Acid Fillers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Biphasic Hyaluronic Acid Fillers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Biphasic Hyaluronic Acid Fillers Overview

3 Products under Development

  • 3.1 Biphasic Hyaluronic Acid Fillers - Pipeline Products by Stage of Development
  • 3.2 Biphasic Hyaluronic Acid Fillers - Pipeline Products by Territory
  • 3.3 Biphasic Hyaluronic Acid Fillers - Pipeline Products by Regulatory Path
  • 3.4 Biphasic Hyaluronic Acid Fillers - Pipeline Products by Estimated Approval Date
  • 3.5 Biphasic Hyaluronic Acid Fillers - Ongoing Clinical Trials

4 Biphasic Hyaluronic Acid Fillers - Pipeline Products under Development by Companies

  • 4.1 Biphasic Hyaluronic Acid Fillers Companies - Pipeline Products by Stage of Development
  • 4.2 Biphasic Hyaluronic Acid Fillers - Pipeline Products by Stage of Development

5 Biphasic Hyaluronic Acid Fillers Companies and Product Overview

  • 5.1 Croma-Pharma GmbH Company Overview
    • 5.1.1 Croma-Pharma GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Hangzhou Singclean Medical Products Co Ltd Company Overview
    • 5.2.1 Hangzhou Singclean Medical Products Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 LG Chem Ltd Company Overview
    • 5.3.1 LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 LifeSprout Inc Company Overview
    • 5.4.1 LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Mesoestetic Pharma Group SL Company Overview
    • 5.5.1 Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Silk Medical Aesthetics Inc Company Overview
    • 5.6.1 Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Sinclair Pharma Ltd Company Overview
    • 5.7.1 Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 SwiftPharma BV Company Overview
    • 5.8.1 SwiftPharma BV Pipeline Products & Ongoing Clinical Trials Overview

6 Appendix

  • 6.1 Methodology
  • 6.2 About GlobalData
  • 6.3 Contact Us
  • 6.4 Disclaimer